Atıf İçin Kopyala
ÜSKÜDAR CANSU D., ÜSKÜDAR TEKE H., TEMEL T., Erturk A., Kahraman O., KORKMAZ C.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, cilt.111, sa.3, ss.262-269, 2019 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
111
Sayı:
3
-
Basım Tarihi:
2019
-
Doi Numarası:
10.1016/j.jnma.2018.10.003
-
Dergi Adı:
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.262-269
-
Anahtar Kelimeler:
Ankylosing spondylitis, Anti-TNF-alfa, Paradoxical adverse events, Inflammatory bowel disease, NECROSIS FACTOR THERAPY, JUVENILE IDIOPATHIC ARTHRITIS, EXTRAARTICULAR MANIFESTATIONS, GUT INFLAMMATION, ADVERSE EVENTS, NEW-ONSET, SPONDYLOARTHROPATHIES
-
Eskişehir Osmangazi Üniversitesi Adresli:
Evet
Özet
Objective: The aim of this study was to determine whether there is any association with anti-tumor necrosis factor (TNF) agent administration and development of new-onset inflammatory bowel disease (IBD) in ankylosing spondylitis (AS) patients.